The anti-inflammatory activity of piperonyl-4-acrylicisobutyl-amide (fagaramide) has been studied. Fagaramide was effective against carrageenan paw oedema in rats and was approximately twenty times less potent than indomethacin, a non-steroidal anti-inflammatory agent. Fagaramide was effective against the prostaglandin phase of an acute experimental inflammatory reaction. It dose-dependently inhibited prostaglandin synthesis in vitro but had no effect on PGE1induced potentiation of carrageenan oedema in indomethacin treated rats. It is thus suggested that at least part of the antiinflammatory activity of fagaramide is mediated via inhibition of prostaglandin synthesis.